The role of catecholamines in mepyramine resistance of anaphylactic bronchospasm in vitro.
D000315:Adrenalectomy; D000707:Anaphylaxis / Q000276:immunology* / Q000401:mortality; D000818:Animals; D001986:Bronchial Spasm / Q000276:immunology* / Q000517:prevention & control; D002395:Catecholamines / Q000378:metabolism*; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007114:Immunization; D008168:Lung / Q000276:immunology; D010047:Ovalbumin; D011725:Pyridines / Q000627:therapeutic use; D011758:Pyrroles; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D014520:Urethane / Q000494:pharmacology
D002395:Catecholamines; D006634:Histamine H1 Antagonists; D011725:Pyridines; D011758:Pyrroles; D013565:Sympatholytics; D014520:Urethane; D006632:Histamine; D012110:Reserpine; D010047:Ovalbumin